Results 211 to 220 of about 337,538 (347)
Mettl3‐Mediated m6A Modification Represents a Novel Therapeutic Target for FSGS
This study explores the roles of Mettl3‐induced N6‐methyladenosine (m6A) modifications in Focal segmental glomerulosclerosis (FSGS). The findings reveal that inhibition of Mettl3 results in podocyte injury by modulating the TJP1CDC42 pathway. Moreover, Administration of N6‐methyladenosine attenuates the FSGS phenotype in WT mice induced by Adriamycin ...
Fubin Zhu +14 more
wiley +1 more source
Giant retroperitoneal mucinous adenocarcinoma of the appendix: a case report. [PDF]
Solomon A +3 more
europepmc +1 more source
Primary Nonseminomatous Germ Cell Tumor of Kidney: An Uncommon Renal Neoplasm
Sonu Kumar Plash +5 more
openalex +1 more source
Multiple Primary Malignant Neoplasms of the Kidney, Rectum and Pancreas: A Case Report [PDF]
Shunda Wang +4 more
openalex
Benefit of a Second Opinion for Lung Cancer: No Metastasis to the Kidney but a Synchronous Primary Renal Neoplasm [PDF]
Marleen J. ter Avest +6 more
openalex +1 more source
This study successfully establishes adamantinomatous craniopharyngioma (ACP) patient‐derived organoids (PDOs) that preserve the histopathological and genetic features of the original tumors. Through drug sensitivity assays and subsequent mechanistic analyses, the study demonstrates that Ceritinib exerts its inhibitory effects on ACP PDO growth by ...
Huarong Zhang +15 more
wiley +1 more source
Rare case of triple kidney with horseshoe fusion. [PDF]
El Aouadi S +7 more
europepmc +1 more source
This study describes a T cell surface engineering strategy that integrates polymer materials with tumor immunology, aiming to achieve broad‐spectrum anti‐tumor applications of glycopolymer‐engineered T (G‐T) cells via non‐genetic modification. Glycopolymer engineering generally modulates immune‐tumor crosstalk through specific cell‐cell interactions ...
Lihua Yao +8 more
wiley +1 more source

